<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://pharmadog.xyz/news/712999</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T20:46:00.000Z</news:publication_date>
      <news:title>FDA rejects Capricor&apos;s Duchenne cell therapy citing serious data integrity violations</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/711567</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T14:01:57.000Z</news:publication_date>
      <news:title>Capricor Therapeutics receives second FDA rejection for Duchenne cell therapy deramiocel</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/711083</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T12:00:00.000Z</news:publication_date>
      <news:title>Debate Over Whether Medical School Should Begin After USMLE Step 1 Exam</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/711039</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T11:00:41.000Z</news:publication_date>
      <news:title>Biopharma newsletter released despite tech outages, highlights Washington political news</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/710747</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T09:30:00.000Z</news:publication_date>
      <news:title>Kennedy and MAHA urged to champion MMR vaccine to curb U.S. measles surge</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/709251</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T01:11:10.000Z</news:publication_date>
      <news:title>FDA rejects Capricor&apos;s Duchenne cell therapy again, citing major trial flaws</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/708851</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T23:43:53.000Z</news:publication_date>
      <news:title>FDA rejects Capricor’s Duchenne cell therapy after trials show no benefit</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/709020</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T23:21:00.000Z</news:publication_date>
      <news:title>Greenwich Rx voluntarily recalls compounded sterile products over sterility concerns</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/708515</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T21:19:27.000Z</news:publication_date>
      <news:title>Princeton graduate student detained by ICE after neuroscience conference, sparking fear among international researchers</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/708347</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T20:26:10.000Z</news:publication_date>
      <news:title>MAHA Institute’s 2025 tax filing reveals cash reserves fell to $171,000 after spending over $1 million</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/708199</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T19:53:09.000Z</news:publication_date>
      <news:title>Compass Pathways and Usona Institute vie for first FDA approval of a psilocybin depression therapy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/708155</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T19:52:42.000Z</news:publication_date>
      <news:title>Lawmakers split on US restrictions for China biotech investments</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/708348</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T19:04:04.000Z</news:publication_date>
      <news:title>Medicare launches pilot to test nutrition and exercise programs as preventive care for chronic disease</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/708594</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T17:58:00.000Z</news:publication_date>
      <news:title>Shanghai San Niu recalls Evergreen and Salt-and-Pepper Soda biscuits over undeclared milk and shrimp allergens</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/707775</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T17:18:00.000Z</news:publication_date>
      <news:title>Erasca reports 44% response in KRAS-mutated pancreatic cancer, eyes Phase 3 trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/707563</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T16:37:46.000Z</news:publication_date>
      <news:title>Novo announces layoff of 215 New Jersey staff as Bausch + Lomb trial misses endpoint</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/707564</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T16:22:25.000Z</news:publication_date>
      <news:title>Revolution Medicines reports strong data for KRAS-targeted pancreatic cancer drug amid rising competition</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/707587</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T16:10:04.000Z</news:publication_date>
      <news:title>FDA delays decision on Savara&apos;s rare lung disease therapy, pushing back deadline</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/707439</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T15:52:19.000Z</news:publication_date>
      <news:title>Ailux appoints former Johnson &amp; Johnson executive Lloyd Miller as chief medical officer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/707395</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T15:31:58.000Z</news:publication_date>
      <news:title>Merck&apos;s sac-TMT antibody-drug conjugate achieves positive Phase 3 results in gastric cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/134233</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T15:14:00.000Z</news:publication_date>
      <news:title>CLINUVEL to cut up to 20% of staff and move headquarters to New York</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/707251</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T14:51:41.000Z</news:publication_date>
      <news:title>RevMed&apos;s Rasonque shows strong first-line response and survival benefit in early pancreatic cancer data</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/707252</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T14:44:57.000Z</news:publication_date>
      <news:title>Sanofi weighs $40 billion Insmed acquisition, seen as strategic fit in respiratory market</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/707271</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T14:16:35.000Z</news:publication_date>
      <news:title>Sanofi considers Insmed acquisition as FDA criticizes J&amp;J bladder cancer drug claims; Japan eyes higher drug prices</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/707272</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T14:01:41.000Z</news:publication_date>
      <news:title>Alterome reports early Phase 1 data for KRAS-targeted therapy in pancreatic, lung and colon cancers</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/707103</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T13:53:10.000Z</news:publication_date>
      <news:title>Scientists study blood markers for chronic traumatic encephalopathy using samples from 21 football players</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/707291</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T13:03:00.000Z</news:publication_date>
      <news:title>Celldex halts eczema development of barzolvolimab after Phase 2 miss, eyes chronic hives filing</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/706891</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T12:36:09.000Z</news:publication_date>
      <news:title>Celldex drops eczema antibody barzolvolimab after Phase 2 failure</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/706892</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T12:11:57.000Z</news:publication_date>
      <news:title>CNS players discuss deals, psychiatry challenges and Alzheimer focus at Jefferies London conference</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/706893</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T12:00:46.000Z</news:publication_date>
      <news:title>Teva appoints interim R&amp;D head as Eric Hughes departs</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/706955</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T12:00:00.000Z</news:publication_date>
      <news:title>China-origin biotech deals and IPOs surge as investors reap early returns, while Summit Therapeutics shares slump</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/706433</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T09:30:00.000Z</news:publication_date>
      <news:title>Exercise should be prescribed alongside rest for concussion recovery, author argues</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/706432</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T09:30:00.000Z</news:publication_date>
      <news:title>FDA leadership search continues as lung cancer drug faces rejection and China’s top drugmakers are ranked</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/706434</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T09:30:00.000Z</news:publication_date>
      <news:title>Only 10% of surgeons in East and Central Africa are women, highlighting gender gap in global surgery</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/706431</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T09:30:00.000Z</news:publication_date>
      <news:title>Patient coalition urges more agency for participants in brain-implant trials</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/707371</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T09:09:00.000Z</news:publication_date>
      <news:title>FDA delays decision on Belite Bio&apos;s Stargardt disease drug to May 12</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/707538</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T07:53:00.000Z</news:publication_date>
      <news:title>Merck’s TROP2 ADC extends survival in pivotal gastroesophageal cancer trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/705987</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T07:23:34.000Z</news:publication_date>
      <news:title>UnitedHealth sues CMS over lowered 2027 Medicare Advantage star ratings</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/707203</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T06:51:00.000Z</news:publication_date>
      <news:title>‘It’s a very healthy sector’: Biopharma gathers in London as M&amp;A shines and China clouds loom</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/707922</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T05:00:00.000Z</news:publication_date>
      <news:title>Heraeus Medevio issues recall of vascular guidewires over coating safety risk</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/706530</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T03:23:00.000Z</news:publication_date>
      <news:title>Bausch + Lomb and Celldex report phase 2 trial failures in atopic dermatitis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/708883</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T00:00:00.000Z</news:publication_date>
      <news:title>ICH Q1 Stability Testing Guideline Revision Expected Within Weeks</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/707785</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T00:00:00.000Z</news:publication_date>
      <news:title>FDA outlines inspection focus on risk management for combination product manufacturers</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/704703</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T00:00:00.000Z</news:publication_date>
      <news:title>Big pharma say they will stop opening new trial sites in Xinjiang and Chinese military hospitals</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/708881</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T00:00:00.000Z</news:publication_date>
      <news:title>FDA faces push for flexible rare-disease trial designs as commissioner&apos;s nomination withdrawn</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/708882</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T00:00:00.000Z</news:publication_date>
      <news:title>Commenters urge FDA to allow flexible trial designs for rare diseases, questioning RCT emphasis</news:title>
    </news:news>
  </url>
</urlset>
